Impairments in agonist-triggered endothelial NO release are evident in women with AE-PCOS and exacerbated by increased circulating inflammatory cytokines, oxidative stress, and NF-κB activation [20] that contribute to the endothelial dysfunction [21] and result in mild hypertension [22]. This evidence concerns the gene NFKB1 and hypertensive disorder.